We report the first measurements of inclusive W and Z boson cross sections times the corresponding leptonic branching ratios for pp collisions at √ s = 1.96 TeV based on the decays of the W and Z bosons into electrons and muons. The data were recorded with the CDF II detector at the Fermilab
4Tevatron and correspond to an integrated luminosity of 72.0 ± 4.3 pb −1 . We test e-µ lepton universality in W decays by measuring the ratio of the W → µν to W → eν cross sections and determine a value of 0.991 ± 0.004(stat.) ± 0.011(syst.) for the ratio of W −ℓ−ν couplings (gµ/ge). Since there is no sign of non-universality, we combine our cross section measurements in the different lepton decay modes and obtain σW ×Br(pp → W → ℓν) = 2.749 ± 0.010(stat.) ± 0.053(syst.) ± 0.165(lum.) nb and σ γ * /Z × Br(pp → γ * /Z → ℓℓ) = 254.9 ± 3.3(stat.) ± 4.6(syst.) ± 15.2(lum.) pb for dilepton pairs in the mass range between 66 GeV/c 2 and 116 GeV/c 2 . We compute the ratio R of the W → ℓν to Z → ℓℓ cross sections taking all correlations among channels into account and obtain R = 10.84 ± 0.15(stat.) ± 0.14(syst.) including a correction for the virtual photon exchange component in our measured γ * /Z → ℓℓ cross section. Based on the measured value of R, we extract values for the W leptonic branching ratio, Br(W → ℓν) = 0.1082 ± 0.0022; the total width of the W boson, Γ(W ) = 2092 ± 42 MeV; and the ratio of W and Z boson total widths, Γ(W )/Γ(Z) = 0.838 ± 0.017. In addition, we use our extracted value of Γ(W ) whose value depends on various electroweak parameters and certain CKM matrix elements to constrain the Vcs CKM matrix element, |Vcs| = 0.976± 0.030.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.